Shiblaq Hisham 4
4 · PROCEPT BioRobotics Corp · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Shiblaq Hisham
EVP, Chief Comm. Officer
Transactions
- Sale
Common Stock
2025-06-06$63.71/sh−12,296$783,397→ 70,837 total - Sale
Common Stock
2025-06-06$64.64/sh−5,904$381,610→ 64,933 total - Sale
Common Stock
2025-06-06$65.35/sh−1,800$117,631→ 63,133 total - Exercise/Conversion
Common Stock
2025-06-06$5.18/sh+20,000$103,600→ 83,133 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-06−20,000→ 11,578 totalExercise: $5.18Exp: 2030-12-15→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The stock option is fully vested and exercisable.